Electra Therapeutics, Inc. (ETRA) Insider Trading

Sector: Biotechnology · Market Cap: $490M · 0 insider purchases in the last 7 days

No open market insider purchases at Electra Therapeutics, Inc. in the last 7 days.

Want more?

Sign up free to see 30+ days of history, set alerts, and track ETRA on your watchlist.

Start for Free

About Electra Therapeutics, Inc. Insider Trading

2 insiders at Electra Therapeutics, Inc. (ETRA) have purchased stock in the past 90 days, totaling $40.0M across 4 transactions (2,666,666 shares).

The most recent purchase was by Director GORDON CARL L on September 21, 2026 — a $5.0M buy of 333,333 shares at $15.00, bringing his total holdings to 5,126,891 shares.

Insiders who purchased: GORDON CARL L (Director, 2 buys totaling $20.0M); ORBIMED ADVISORS LLC (Director, 2 buys totaling $20.0M).

This insider buying is notable given that ETRA had no recorded open market purchases in the nine months before that.

ETRA is in the Biotechnology sector within the Biotechnology industry with a market cap of $490M.

Track ETRA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.

More Insider Trading in Biotechnology

Related Screeners